Omnicell (OMCL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stan Berenshteyn from Wells Fargo maintained a Hold rating on the stock and has ...
Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has ...
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) ...
Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results